Identification of Pathway Deregulation – Gene Expression Based Analysis of Consistent Signal Transduction
暂无分享,去创建一个
Bozena Kaminska | Jakub Mieczkowski | B. Kamińska | J. Mieczkowski | Karolina Swiatek-Machado | Karolina Swiatek-Machado
[1] P DESAIVE,et al. [Thyroid cancer]. , 1951, Revue medicale de Liege.
[2] H. Leffers,et al. Expression of the vitamin D receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[3] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[4] Paolo P. Provenzano,et al. Tumorigenesis and Neoplastic Progression Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer , 2008 .
[5] R. Tibshirani,et al. On testing the significance of sets of genes , 2006, math/0610667.
[6] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[7] Fan Wang,et al. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer , 2008, International Journal of Colorectal Disease.
[8] Michal A. Kurowski,et al. Transcriptome Profile of Human Colorectal Adenomas , 2007, Molecular Cancer Research.
[9] Greg Finak,et al. Regulation of endocytosis via the oxygen-sensing pathway , 2009, Nature Medicine.
[10] Hans-Werner Mewes,et al. Interpreting Clusters of Gene Expression Profiles in Terms of Metabolic Pathways , 1999, German Conference on Bioinformatics.
[11] Cengizhan Ozturk,et al. Pathway analysis of high-throughput biological data within a Bayesian network framework , 2011, Bioinform..
[12] Ola Larsson,et al. Lack of correct data format and comparability limits future integrative microarray research , 2006, Nature Biotechnology.
[13] Timothy Hunter,et al. Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer , 2009, Breast Cancer Research and Treatment.
[14] Patrick Neven,et al. Endometrial cancer. , 2005, Lancet.
[15] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] Kenneth H. Buetow,et al. PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..
[17] Frank Emmert-Streib,et al. The Chronic Fatigue Syndrome: A Comparative Pathway Analysis , 2007, J. Comput. Biol..
[18] S. Chalmers,et al. Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88. , 2012, Cellular immunology.
[19] C. Sawyers,et al. Targeted cancer therapy , 2004, Nature.
[20] M. Abreu,et al. Microflora in colorectal cancer: a friend to fear , 2010, Nature Medicine.
[21] Eytan Domany,et al. Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.
[22] Paul Pavlidis,et al. A methodology for the analysis of differential coexpression across the human lifespan , 2009, BMC Bioinformatics.
[23] Atul J. Butte,et al. Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..
[24] Angela P. Presson,et al. Integrated Weighted Gene Co-expression Network Analysis with an Application to Chronic Fatigue Syndrome , 2008, BMC Systems Biology.
[25] M. Abreu,et al. Role of Toll-like receptors in gastrointestinal malignancies , 2008, Oncogene.
[26] Michal Dabrowski,et al. Probe set filtering increases correlation between Affymetrix GeneChip and qRT-PCR expression measurements , 2010, BMC Bioinformatics.
[27] Yoav Benjamini,et al. Identifying differentially expressed genes using false discovery rate controlling procedures , 2003, Bioinform..
[28] Crispin J. Miller,et al. Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis , 2005, Bioinform..
[29] Andrew B. Nobel,et al. Significance analysis of functional categories in gene expression studies: a structured permutation approach , 2005, Bioinform..
[30] Christina Backes,et al. A novel algorithm for detecting differentially regulated paths based on gene set enrichment analysis , 2009, Bioinform..
[31] Susumu Goto,et al. KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..
[32] Marie Joseph,et al. Gene Signatures of Progression and Metastasis in Renal Cell Cancer , 2005, Clinical Cancer Research.
[33] Victoria Kristina Perry,et al. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients , 2007, International journal of cancer.
[34] J. Yuen. Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future , 2009, Indian journal of urology : IJU : journal of the Urological Society of India.
[35] J. Pollack,et al. A gene expression signature of genetic instability in colon cancer. , 2005, Cancer research.
[36] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[37] Charles Swanton,et al. Genetic prognostic and predictive markers in colorectal cancer , 2011, Nature Reviews Cancer.
[38] P. J. van der Spek,et al. HPV related VIN: Highly proliferative and diminished responsiveness to extracellular signals , 2007, International journal of cancer.
[39] Sampsa Hautaniemi,et al. Candidate driver genes in microsatellite‐unstable colorectal cancer , 2012, International journal of cancer.
[40] J. Nevins,et al. Linking oncogenic pathways with therapeutic opportunities , 2006, Nature Reviews Cancer.
[41] Jongdae Lee,et al. ERK activation drives intestinal tumorigenesis in Apcmin/+ mice , 2010, Nature Medicine.
[42] Z. Qian,et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer , 2010, British Journal of Cancer.
[43] Jolyon Terragni,et al. The E-box Binding Factors Max/Mnt, MITF, and USF1 Act Coordinately with FoxO to Regulate Expression of Proapoptotic and Cell Cycle Control Genes by Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3 Signaling* , 2011, The Journal of Biological Chemistry.
[44] T. Ørntoft,et al. Gene expression signatures for colorectal cancer microsatellite status and HNPCC , 2005, British Journal of Cancer.
[45] P. Fernández-Llama,et al. Transportadores de sodio y aquaporinas: ¿futuros biomarcadores renales? , 2007 .
[46] K. Ho,et al. A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis , 2007, Clinical Cancer Research.
[47] Dennis B. Troup,et al. NCBI GEO: archive for high-throughput functional genomic data , 2008, Nucleic Acids Res..
[48] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[49] Thomas Downey,et al. A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics , 2010, Clinical & Experimental Metastasis.
[50] Seon-Young Kim,et al. Gene-set approach for expression pattern analysis , 2008, Briefings Bioinform..